Bio-Connect
Human TIMP-2 PicoKine ELISA Kit standard curve
Human TIMP-2 PicoKine ELISA Kit standard curve
Human TIMP-2 PicoKine ELISA Kit standard curve

Human TIMP-2 ELISA Kit PicoKine(r)

EK0522
Boster Bio
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human TIMP-2 PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    156 pg/ml - 10,000 pg/ml
  • Assay Sensitivity
    <2 pg/ml
  • Assay Time
    25-30
  • Certification
    Research Use Only
  • Scientific Description
    Human TIMP-2 ELISA Kit PicoKine® (96 Tests). Quantitate Human TIMP2 in cell culture supernatants, serum, plasma (heparin, EDTA) and saliva. Sensitivity: 2pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity Supplier
    Human TIMP-2
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Di Stefano V, Tubiolo C, Gagliardo A, et al. Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study. Brain Sci. 2022,12(11). doi: 10.3390/brainsci12111439
    Read this paper
  • Cosentino G, Di Stefano V, Presti RL, et al. Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropathy. Neurol Sci. 2021,42(10):4297-4300. doi: 10.1007/s10072-021-05314-y
    Read this paper
  • Zhang WJ, Song B, Yang T. MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma. Cancer Manag Res. 2019,11:10675-10681. doi: 10.2147/CMAR.S233776
    Read this paper
  • Hopps E, Canino B, Montana M, et al. Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome. Clin Hemorheol Microcirc. 2016,62(1):27-34. doi: 10.3233/CH-151928
    Read this paper
  • Caimi G, Ferrara F, Montana M, et al. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers. Clin Hemorheol Microcirc. 2015,60(3):309-16. doi: 10.3233/CH-141863
    Read this paper
  • Hopps E, Lo Presti R, Montana M, et al. Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome. Mediators Inflamm. 2014,2014:510619. doi: 10.1155/2014/510619
    Read this paper
  • Hopps E, Lo Presti R, Montana M, et al. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome. J Investig Med. 2013,61(6):978-83. doi: 10.2310/JIM.0b013e318294e9da
    Read this paper
  • Kim KS, Lee YA, Choi HM, et al. Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13. Rheumatol Int. 2012,32(10):3069-75.
    Read this paper
  • Yu X, Zhu J, Mi M, et al. Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med Oncol. 2012,29(1):349-57. doi: 10.1007/s12032-010-9770-2
    Read this paper